Global Pharmaceutical Survey 2012–2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical IndustryiCD ResearchMarch 9, 2012 153 Pages - SKU: ICDR3805165 |
|
Delcath Systems, Inc. (DCTH) - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
Summary Delcath Systems, Inc. (Delcath) is a US-based development stage, specialty pharmaceutical and medical device company. It specializes in developing percutaneous perfusion technologies for the targeted administration of high-dose chemotherapeutic agents to treat primary and metastatic
|
read more...
|
$750.00
|
|
Hadasit Medical Research Services & Development Ltd - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
Summary Hadasit Medical Research Services & Development Ltd (Hadasit Ltd) is a biomedical technology company. It provides, promotes and commercializeS pre-clinical and clinical research and development capabilities through product licensing, establishing start-up companies and collaboration with
|
read more...
|
$750.00
|
|
Mystic Pharmaceuticals, Inc. - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
Summary Mystic Pharmaceuticals, Inc. (Mystic) is a pharmaceutical service company. The company develops and commercializes drug delivery systems. It offers services such as device manufacturing, drug compounding, sterilization filtration, aseptic form fill seal blister production, packaging
|
read more...
|
$750.00
|
|
Randox Laboratories Ltd. - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
Summary Randox Laboratories Ltd. (Randox) is a pharmaceutical and healthcare company. It develops and manufactures diagnostic kits for biochemistry laboratories. Its major product categories include biochip analyzers, biochip immunoassays, biochip molecular diagnostics, cardiovascular biomarkers and regents,
|
read more...
|
$750.00
|
|
Partnerships, Licensing, Investments and M&A Deals and Trends for April 2013 in Pharmaceuticals
5/15/2013 | published by: GlobalData
Partnerships, Licensing, Investments and M&A Deals and Trends for April 2013 in Pharmaceuticals Summary GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for April 2013 in Pharmaceuticals” report is an essential source of data and trend
|
read more...
|
$1,000.00
|
|
HubSpot: Inbound Marketing Software Reaches Europe
5/16/2013 | published by: IDC
This IDC Vendor Profile assesses HubSpot, a marketing software company that helps organizations manage their marketing activities from a single cloud-based platform. The software is designed to increase website traffic and convert website visitors into
|
read more...
|
$3,500.00
|
|
CompetitiveWatch Food and Beverage: Leading Suppliers, Technological Know-How, Marketing Tatics, Strategic Directions
5/14/2013 | published by: Venture Planning Group
The report analyzes: Internally developed and acquired technologies, processes and related capabilities. Proprietary know-how and patent litigations. Estimated R&D budget. Research facilities and staff. New technologies, products, and product line extensions in development. The companies analyzed in the report: Cargill, Coca-Cola,
|
read more...
|
$2,450.00
|
|
Consumer Health in Hong Kong, China
5/17/2013 | published by: Euromonitor International
Consumer Health in Hong Kong, China The total consumer health industry saw a healthy 7% growth in 2012 to reach HK$6.6 billion. It is supported by a strong sense of health consciousness amongst Hong Kong people.
|
read more...
|
$2,400.00
|
|
A&G Pharmaceutical, Inc. - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
Summary A&G Pharmaceutical, Inc. (A&G) is a pharmaceutical company. The company discovers, develops and markets pharmaceutical products which improve screening, monitoring, and targeted treatment of cancer. Its products include biopsy staining kits, serum monitoring kits, GP88-based
|
read more...
|
$750.00
|
|
AcelRx Pharmaceuticals, Inc. (ACRX) - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
Summary AcelRx Pharmaceuticals, Inc. (AcelRx) is a specialty pharmaceutical company. It focuses on the development and marketing of novel therapies for the diagnosis of pain and other related disorders. The company's pipeline product portfolio includes ARX-01,
|
read more...
|
$750.00
|
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
Pharmaceuticals Company Reports
- PharmaSphere: Early-Stage Technology Transfer Collaborations - Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical Industry
- Notable News in the Life Sciences: 1Q13
- Immunomedics, Inc. – Product Pipeline Review – 2013
- Richter Gedeon Nyrt. – Product Pipeline Review – 2013
- Noven Pharmaceuticals, Inc. – Product Pipeline Review – 2013